Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Miller

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
International Journal of Pharmaceutics|April 11, 2020
The solubility, permeability and the dose as key factors in formulation development for oral lipophilic drugs: Maximizing the bioavailability of carbamazepine with a cosolvent-based formulationNoa Fine-Shamir, Avital Beig, Jonathan M Miller, et al.
Journal of the American Veterinary Medical Association|March 4, 2008
What is your diagnosis? Periarticular osteophyte production, cortical remodeling, and stifle joint effusion are evidentTisha A M Harper, Jonathan M Miller, Dean E Filipowicz
Frontiers in Pharmacology|November 10, 2016
Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability InterplayAvital Beig, David Lindley, Jonathan M Miller, et al.
The AAPS Journal|December 18, 2012
The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membraneArik Dahan, Avital Beig, Viktoriya Ioffe-Dahan, et al.
Molecular Pharmaceutics|June 12, 2010
Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivirJonathan M Miller, Arik Dahan, Deepak Gupta, et al.
Journal of Child Neurology|March 29, 2006
Behavioral therapy for treatment of stereotypic movements in nonautistic childrenJonathan M Miller, Harvey S Singer, Dana D Bridges, et al.
Health & Place|June 17, 2020
Are low income children more physically active when they live in homes with bigger yards? A longitudinal analysis of the NET-Works StudyJonathan M Miller, Yingling Fan, Nancy E Sherwood, et al.
The AAPS Journal|February 17, 2017
Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the PermeabilityAvital Beig, Noa Fine-Shamir, David Lindley, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 7, 2009
Quasi-equilibrium analysis of the ion-pair mediated membrane transport of low-permeability drugsJonathan M Miller, Arik Dahan, Deepak Gupta, et al.
Hospital Pediatrics|February 14, 2024
How Will a Shift to Value-Based Financial Models Affect Care for Hospitalized Children?David I Rappaport, Karen Marie Wilding, Lisa Adkins, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
International Journal of Pharmaceutics|April 11, 2020
The solubility, permeability and the dose as key factors in formulation development for oral lipophilic drugs: Maximizing the bioavailability of carbamazepine with a cosolvent-based formulationNoa Fine-Shamir, Avital Beig, Jonathan M Miller, et al.
Journal of the American Veterinary Medical Association|March 4, 2008
What is your diagnosis? Periarticular osteophyte production, cortical remodeling, and stifle joint effusion are evidentTisha A M Harper, Jonathan M Miller, Dean E Filipowicz
Frontiers in Pharmacology|November 10, 2016
Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability InterplayAvital Beig, David Lindley, Jonathan M Miller, et al.
The AAPS Journal|December 18, 2012
The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membraneArik Dahan, Avital Beig, Viktoriya Ioffe-Dahan, et al.
Molecular Pharmaceutics|June 12, 2010
Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivirJonathan M Miller, Arik Dahan, Deepak Gupta, et al.
Journal of Child Neurology|March 29, 2006
Behavioral therapy for treatment of stereotypic movements in nonautistic childrenJonathan M Miller, Harvey S Singer, Dana D Bridges, et al.
Health & Place|June 17, 2020
Are low income children more physically active when they live in homes with bigger yards? A longitudinal analysis of the NET-Works StudyJonathan M Miller, Yingling Fan, Nancy E Sherwood, et al.
The AAPS Journal|February 17, 2017
Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the PermeabilityAvital Beig, Noa Fine-Shamir, David Lindley, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 7, 2009
Quasi-equilibrium analysis of the ion-pair mediated membrane transport of low-permeability drugsJonathan M Miller, Arik Dahan, Deepak Gupta, et al.
Hospital Pediatrics|February 14, 2024
How Will a Shift to Value-Based Financial Models Affect Care for Hospitalized Children?David I Rappaport, Karen Marie Wilding, Lisa Adkins, et al.
Pageof 10